Skip to content
★ Sign in to follow
Total declarations
197
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (74 ops.)
€30.3M

Latest filing published 07 Aug 2015 for Regeneron Pharmaceuticals, INC., €261k.

Insider track record

Disclosed buys
0
Disclosed sells
74
Signal history

No signal scores available.

Alfred G. Gilman: trading record in brief

Alfred G. Gilman discloses dealings in 2 companies, chiefly Regeneron Pharmaceuticals, Inc. and ELI LILLY & Co. Over a trading history stretching from 27 December 2005 to 6 August 2015, the count stands at 197 filings.

No open-market purchase appears, only 74 sales worth €30.3M. Outside the open market, there are 13 share grants and 63 option exercises. 2015 to date brings no purchases and 12 sales.

The record was last updated on 7 August 2015 with an option exercise (€261k) in Regeneron Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Alfred G. Gilman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations170 total

25 of 170 declarations